PACS Group, Price To Sales Ratio Over Time
PACS Stock | 15.61 0.10 0.64% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out PACS Group, Performance and PACS Group, Correlation. PACS |
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of PACS Group,. If investors know PACS will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about PACS Group, listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share 0.61 | Revenue Per Share 26.578 | Quarterly Revenue Growth 0.291 |
The market value of PACS Group, is measured differently than its book value, which is the value of PACS that is recorded on the company's balance sheet. Investors also form their own opinion of PACS Group,'s value that differs from its market value or its book value, called intrinsic value, which is PACS Group,'s true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because PACS Group,'s market value can be influenced by many factors that don't directly affect PACS Group,'s underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between PACS Group,'s value and its price as these two are different measures arrived at by different means. Investors typically determine if PACS Group, is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, PACS Group,'s price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cross Equities Price To Sales Ratio Analysis
Compare PACS Group, and related stocks such as Luxfer Holdings PLC, CF Industries Holdings, and Papaya Growth Opportunity Price To Sales Ratio Over Time
Select Fundamental2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
LXFR | 0.6113 | 0.5696 | 0.2576 | 0.5811 | 0.8201 | 0.5755 | 0.6942 | 0.9516 | 0.9651 | 1.1389 | 1.3931 | 1.4297 | 0.8848 | 0.5937 | 0.56 |
CF | 0.7684 | 1.6502 | 2.1267 | 2.5073 | 2.942 | 2.2289 | 1.9885 | 2.4051 | 2.285 | 2.2903 | 2.0172 | 2.3276 | 1.5485 | 2.3175 | 1.37 |
PPYAU | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
APD | 0.7935 | 1.6831 | 2.0294 | 2.4522 | 2.5617 | 4.0083 | 4.0263 | 4.1607 | 5.48 | 7.4395 | 5.4978 | 4.0686 | 5.0 | 5.4747 | 5.75 |
VMI | 0.6163 | 0.8982 | 1.4816 | 1.4816 | 1.4816 | 1.4816 | 1.2607 | 1.4816 | 1.4816 | 1.4816 | 1.4816 | 1.1722 | 1.6217 | 1.46 | 1.53 |
NL | 0.4271 | 4.5456 | 6.6979 | 5.8984 | 4.0331 | 1.3579 | 3.6447 | 6.1976 | 1.447 | 1.5346 | 2.0362 | 2.5646 | 1.9952 | 1.6983 | 1.56 |
PACS Group, and related stocks such as Luxfer Holdings PLC, CF Industries Holdings, and Papaya Growth Opportunity Price To Sales Ratio description
Price to Sales Ratio is figured by comparing PACS Group, stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on PACS Group, sales, a figure that is much harder to manipulate than other PACS Group, multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.My Equities
My Current Equities and Potential Positions
PACS Group, | PACS |
Specialization | Health Care, Health Care Equipment & Services |
Location | Utah; U.S.A |
Exchange | New York Stock Exchange |
null 15.61
Additional Tools for PACS Stock Analysis
When running PACS Group,'s price analysis, check to measure PACS Group,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy PACS Group, is operating at the current time. Most of PACS Group,'s value examination focuses on studying past and present price action to predict the probability of PACS Group,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move PACS Group,'s price. Additionally, you may evaluate how the addition of PACS Group, to your portfolios can decrease your overall portfolio volatility.